This 2020 study, published in the Journal of Biological Chemistry, investigates the effects of low-dose naltrexone (LDN) on inflammation and insulin resistance induced by hyperinsulinemia. Using in vitro models, the researchers demonstrated that LDN treatment reduced pro-inflammatory cytokine production and improved insulin signaling pathways. The findings suggest that LDN may
